Search Results - "Isaeva, O.I."

474P ctDNA-based copy number dynamics during anti-PD1 treatment in patients with metastatic triple-negative breast cancer by Lin, A.Y., Isaeva, O.I., Vessies, D., Deger, T., Voorwerk, L., Geurts, V., Horlings, H., Martens, J., Wessels, L., Van Den Broek, D., Kok, M.

Get full text

LBA13 Nivolumab and ipilimumab in early-stage triple negative breast cancer (TNBC) with tumor-infiltrating lymphocytes (TILs): First results from the BELLINI trial by Nederlof, I., Isaeva, O.I., Bakker, N., de Graaf, M., Salgado, R.F., Klioueva, N., Van De Vijver, K., van Duijnhoven, F., Kalashnikova, E., Willingham, S., Luykx, S., Loo, C.E., Kerver, E., Sonke, G.S., Blank, C.U., Mann, R., Linn, S.C., Lambrechts, D., Horlings, H., Kok, M.

Get full text

LBA10 Critical role of eosinophils during response to immune checkpoint blockade in breast cancer and other cancer types by Voorwerk, L., Garner, H., Blomberg, O.S., Spagnuolo, L., Chalabi, M., van Dyk, E., Isaeva, O.I., Bakker, N., Klaver, C., Duijst, M., Kersten, K., Hoes, L.R., van Dorp, J., van der Heijden, M.S., Theelen, W.S.M.E., Voest, E.E., Wessels, L.F., de Visser, K.E., Kok, M.

Get full text

163MO Single-cell T cell dynamics induced by neoadjuvant nivolumab +/- ipilimumab in early triple negative breast cancer with tumor-infiltrating lymphocytes (BELLINI trial) by Isaeva, O.I., Nederlof, I., de Graaf, M., Boeckx, B., Traets, J., Mandjes, I.A.M., Van De Vijver, K., Chelushkin, M., Drukker, C., Dongen, M.V., Sonke, G.S., Linn, S.C., Blank, C.U., de Visser, K.E., Salgado, R.F., Wessels, L.F.A., Schumacher, T.N., Horlings, H.M., Lambrechts, D., Kok, M.

Get full text